Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
eli lilly
fda
indiana blog main
indiana top stories
life sciences
national blog main
teva pharmaceutical
amgen
boston blog main
raleigh-durham blog main
raleigh-durham top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
detroit blog main
detroit top stories
fremanezumab
migraine
migraine research foundation
national
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
drugs
episodic migraine
What
approval
9
×
drug
9
×
new
9
×
fda
administration
food
migraine
won
class
medicines
announced
companies
decades
developed
device
eli
lilly
medical
pain
prevent
starts
accessory
acute
addresses
advisory
alivecor’s
alternative
american
amgen
apple
approved
approving
arguments
attacks
big
bio
biogen’s
biopharmaceutical
blood
brand
Language
unset
Current search:
approval
×
new
×
drug
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@slashgear.com
4 years ago
The FDA just fast-tracked this new blood cancer treatment
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
@techcrunch.com
6 years ago
FDA clears AliveCor’s Kardiaband as the first medical device accessory for the Apple Watch
@techcrunch.com
8 years ago
Whill receives FDA approval for the Model M, its new mobility device
@theverge.com
8 years ago
FDA panel recommends approving new drug that dramatically lowers cholesterol